ABCSG takes part in the IBIS-II-study

5.000 women have already been recruited to IBIS II worldwide, even more are needed

www.ibis-trials.org

Pressrelease

Press release: Study results of ABCSG-24

Presentation: ORAL presentation, Wednesday 23 September 2009, 13.15-13.30 CET,
joint 15th ECCO and 34th ESMO, Berlin, Germany.

Pressrelease

The Lancet Oncology published the substudy of the ABCSG-12

Concomitant zoledronic acid prevents bone loss in women with breast cancer during treatment with adjuvant endocrine therapy, and improves bone-mineral density after treatment, according to findings from a substudy of the Austrian Breast and Colorectal Cancer Study Group trial-12 (ABCSG-12), published early Online and in the September edition of The Lancet Oncology.


Pressrelease

Breast cancer: Clear improvements in young patients’ chances of survival

ABCSG study results attract worldwide attention at US presentation


Pressrelease